These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3026007)

  • 21. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
    Heizmann W; Heilmann F; Werner H
    Infection; 1987; 15(5):370-4. PubMed ID: 3692611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramuscular sulbactam/ampicillin combination therapy in gynaecological and obstetric bacterial infections.
    Abbassi AF; Said A; Gaber A
    J Int Med Res; 1991; 19 Suppl 1():44A-49A. PubMed ID: 2060693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
    Hemsell DL
    Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
    Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ikegawa A; Seto H; Hogaki M; Arai K
    Jpn J Antibiot; 1984 Nov; 37(11):2188-92. PubMed ID: 6098711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of infections due to multiresistant Neisseria gonorrhoeae with sulbactam/ampicillin.
    Kim JH; Choi KH; Kim YT; Yang IS
    Rev Infect Dis; 1986; 8 Suppl 5():S599-603. PubMed ID: 3026010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
    Rev Infect Dis; 1986; 8 Suppl 5():S465-650. PubMed ID: 3025995
    [No Abstract]   [Full Text] [Related]  

  • 29. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.
    Huang LM; Lee CY; Lee MJ; Hsu CY; Liu CC; Hong JY; Chen JM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(2):87-93. PubMed ID: 2637593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin.
    Dørflinger T; Madsen PO
    Infection; 1985; 13(2):66-9. PubMed ID: 2987133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H; Heizmann W; Heilmann F
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampicillin combined with sulbactam or metronidazole for single-dose chemoprophylaxis in major gynaecological surgery.
    Houang ET; Watson C; Howell R; Chapman M
    J Antimicrob Chemother; 1984 Nov; 14(5):529-35. PubMed ID: 6096349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
    Lee CY; Lin TY; Chu ML; Lee MJ; Hsu CY; Huang LM; Chen CM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):179S-183S. PubMed ID: 2686918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
    Wald E; Reilly JS; Bluestone CD; Chiponis D
    Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
    Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
    Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.